SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in...

Proceedings of the National Academy of Sciences 2008 / 04 Vol. 105; Iss. 14

SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in vitro resistance when combined with nilotinib or dasatinib

O'Hare, T., Eide, C. A., Tyner, J. W., Corbin, A. S., Wong, M. J., Buchanan, S., Holme, K., Jessen, K. A., Tang, C., Lewis, H. A., Romero, R. D., Burley, S. K., Deininger, M. W.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
105
Language:
english
Journal:
Proceedings of the National Academy of Sciences
DOI:
10.1073/pnas.0800587105
Date:
April, 2008
File:
PDF, 386 KB
english, 2008
Conversion to is in progress
Conversion to is failed